FDA Clears Serina's Advanced Parkinson's Disease Drug for Clinical Trial

Serina Therapeutics receives FDA IND clearance for SER-252, advancing toward Phase 1b clinical study for advanced Parkinson's disease treatment using POZ platform technology.